KRTAP9-10P

Across TCGA pan-cancer cohorts, KRTAP9-10P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KRTAP9-10P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher KRTAP9-10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP9-10P expression acts as an unfavorable survival marker.

STAD, LIHC, and BRCA are the cancer types where KRTAP9-10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.215	0.649	.005	57	view →
LIHC	OS	Tertile	All	0.118	0.783	<.001	54	view →
BRCA	DFS	Tertile	All	0.562	0.949	.020	36	view →
UCEC	DFS	Tertile	All	0.550	0.899	<.001	36	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	18	view →
LAML	DFS	Tertile	All	0.165	0.581	.034	18	view →
KIRP	OS	Tertile	All	0.599	0.903	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KRTAP9-10P–STAD (OS)

Open the STAD breakdown →